PATENT CLAIM ANALYSIS

Application Number: 15939822
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "298000"]

Abstract:
This invention relates to the use of low doses of (+)-α-dihydrotetrabenazine for the treatment of movement disorders, such as Tourette's syndrome.

Claim (Index 11):
A method of treating a movement disorder in a subject in need thereof, which treatment comprises administering to the subject an effective amount of (+)-\u03b1-dihydrotetrabenazine or a pharmaceutically acceptable salt thereof, wherein the said effective amount corresponds to an amount of (+)-\u03b1-dihydrotetrabenazine free base of from 0.05 mg/kg to 0.3 mg/kg per day.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 90.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15939826', '15939837', '12555695', '14442996', '15629314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.788449326212474
- 35 USC 102 Novelty (BERT): 0.6209814434916056
- Combined Prediction Score: 0.7717025379403872
- Mean Citation Score: 434.760146
- Max Citation Score: 659.07886
- Similarity Product: 476.8665845281912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test